Bupropion clinical trials
Also written Zyban, Wellbutrin and Amfebutamone.
Includes 19 studies of Bupropion Hydrochloride Controlled-release and 1 study of Bupropion hydrobromide.
How each study uses Bupropion is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Bupropion studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 30 Dec 1985 · WELLBUTRIN · NDA 018644 (FDA, Drugs@FDA)
- European Union
- 26 Mar 2015 · Mysimba · EMEA/H/C/003687 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- Amfebutamone
- 2
Studies by the year they started
213 studies that test it; most in 2004 (21); 2 more planned to start later
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1995 | 1 |
| 1998 | 4 |
| 1999 | 3 |
| 2000 | 4 |
| 2001 | 7 |
| 2002 | 10 |
| 2003 | 8 |
| 2004 | 21 |
| 2005 | 21 |
| 2006 | 6 |
| 2007 | 8 |
| 2008 | 5 |
| 2009 | 9 |
| 2010 | 9 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 4 |
| 2016 | 10 |
| 2017 | 10 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 12 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 31 · Other 186
National Institute on Drug Abuse (NIDA) (16) · New York State Psychiatric Institute (11) · GlaxoSmithKline (9) · Duke University (8) · Yale University (7) · Mayo Clinic (6) · M.D. Anderson Cancer Center (5) · Centre for Addiction and Mental Health (5)
Often tested with
Tested in the same studies.
Naltrexone (22) · Varenicline (20) · Nicotine (18) · Escitalopram (14) · Nicotine Patch (7) · Aripiprazole (7) · Sertraline (6) · Nicotine Replacement (6)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3, 1 in phase 3
Studies that test Bupropion, phase 3 first.
- Jan 2027Improving Smoking Abstinence Outcomes in the African American Community Through Extended TreatmentPhase 3 · University of Kansas Medical Center
- Apr 2027Predictors of Cognitive Outcomes in Geriatric DepressionPhase 4 · David Steffens
- Jul 2027Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)Phase 4 · Carmen Dietvorst
Studies
Open first, then newest update. How each study uses Bupropion is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 217
- The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression.Not yet recruitingPhase 2Washington University School of MedicineNCT07810738Written as Bupropion Augmentation
- Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)RecruitingPhase 3Axsome Therapeutics, Inc.NCT07766655Written as Bupropion
- Bupropion for Fatigue in End-stage Kidney Disease Patients on HemodialysisNot yet recruitingPhase 1/2The University of Texas Health Science Center at San AntonioNCT06609343Written as Bupropion Hydrochloride 150 MG
- Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I TrialRecruitingPhase 4M.D. Anderson Cancer CenterNCT04604509Written as Bupropion Hydrochloride Controlled-release
- Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive DisorderNot yet recruitingPhase 4Bausch Health Americas, Inc.NCT02129751Written as bupropion hydrobromide
- Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery PatientsNot yet recruitingPhase 1Medical University of South CarolinaNCT07224087Written as Bupropion HCl Extended Release
- Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic RiskNot yet recruitingPhase 3Uppsala UniversityNCT07806279Written as Bupropion 150 mg
- A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery PatientsNot yet recruitingPhase 1/2Medical University of South CarolinaNCT07398404Written as Bupropion Hydrochloride Extended-release
- Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)Enrolling by invitationPhase 4Carmen DietvorstNCT06845345Written as Mysimba
- Individualized Pharmacological Approach to Obesity in Patients With Bipolar DisorderRecruitingPhase 4Mayo ClinicNCT07213466Written as naltrexone and bupropion (combination)
- Improving Smoking Abstinence Outcomes in the African American Community Through Extended TreatmentRecruitingPhase 3University of Kansas Medical CenterNCT05732272Written as Bupropion
- The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.RecruitingPhase 3Dr. Inge WinterNCT05973786Written as Bupropion
- Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release TabletRecruitingPhase 4Laval UniversityNCT06620562Written as Naltrexone/Bupropion
- Effectiveness of Combined Tobacco Treatment in Hospitalized SubjectsRecruitingPhase 4National Institute of Respiratory Diseases, MexicoNCT06254001Written as Bupropion
- Tobacco Treatment Optimization and Preferences During Concurrent Cancer TreatmentCompletedPhase 2Joseph Valentino, MDNCT04634071Written as Bupropion
- Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment FailureTerminatedPhase 3Dr. Inge WinterNCT05603104Written as Bupropion
- SMART Trial to Predict Anhedonia Response to Antidepressant TreatmentCompletedPhase 4Mclean HospitalNCT05537584Written as Bupropion
- Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use DisorderCompletedPhase 3University of Texas Southwestern Medical CenterNCT03078075Written as Bupropion: Wellbutrin XL®
- Bupropion to Reduce Cancer Related Fatigue in Cancer SurvivorsActive, not recruitingPhase 3University of Rochester NCORP Research BaseNCT03996265Written as Bupropion Hydrochloride Controlled-release
- Pharmacological and Behavioral Treatment After Bariatric SurgeryCompletedPhase 3Yale UniversityNCT05157698Written as Naltrexone and Bupropion Combination
See all 217 studies that test Bupropion →
Given beside what is tested · 39 — Bupropion is usual care or a partner of the new treatment
- A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination TherapyRecruitingPhase 3Hoffmann-La RocheNCT05646862Written as Bupropion
- Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation TrialNot yet recruitingPhase 4Yale UniversityNCT07835555Written as nicotine patch, nicotine gum, nicotine lozenge, varenicline, bupropion
- BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire DisorderNot yet recruitingPhase 1/2University of Illinois at ChicagoNCT07596212Written as Bupropion
- Abstinence Reinforcement Therapy for Veterans Who Smoke Tobacco and Are Experiencing HomelessnessNot yet recruitingNot applicableVA Office of Research and DevelopmentNCT07714200Written as Bupropion
- A Phase 1, First-in-human Study of VX-433RecruitingPhase 1Vertex Pharmaceuticals IncorporatedNCT07584434Written as Bupropion
- Safety and PK Study of BICX104 With or Without Bupropion Compared to VivitrolRecruitingPhase 1BioCorRx Pharmaceuticals IncNCT07269873Written as Bupropion 150 mg XL
- PARQuit Smoking Cessation Intervention for Adults With Serious Mental IllnessCompletedPhase 4University of California, San FranciscoNCT03950427Written as Bupropion
- CPT-SMART for Treatment of PTSD and Cigarette SmokingCompletedPhase 4VA Office of Research and DevelopmentNCT03978442Written as Bupropion
- A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the BloodCompletedPhase 1Boehringer IngelheimNCT06367153Written as Bupropion
- Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSDCompletedNot applicableDuke UniversityNCT01990079Written as Bupropion
- A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or ObesityCompletedPhase 1Boehringer IngelheimNCT06564441Written as Bupropion
- Metabolism-informed Care for Smoking CessationCompletedNot applicableVanderbilt University Medical CenterNCT03227679Written as Bupropion
- A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy ParticipantsCompletedPhase 1AstraZenecaNCT06973005Written as Bupropion
- A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant DepressionWithdrawnPhase 3Janssen-Cilag International NVNCT03852160Written as Bupropion
- A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05932277Written as Bupropion
- Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy ParticipantsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT04526210Written as Bupropion Hydrochloride
- Individualized Obesity PharmacotherapyCompletedPhase 3Mayo ClinicNCT03374956Written as Naltrexone/bupropion
- Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and ZybanTerminatedPhase 4Yale UniversityNCT00511134Written as Bupropion
- A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235WithdrawnPhase 1Bristol-Myers SquibbNCT04464577Written as Bupropion
- Abstinence Reinforcement Therapy (ART) for Homeless Veteran SmokersCompletedPhase 4VA Office of Research and DevelopmentNCT02245308Written as Bupropion
Showing 20 of 39.
As the comparator · 12 — what is tested is compared with Bupropion
- A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsRecruitingPhase 4Axsome Therapeutics, Inc.NCT06223880Written as Bupropion
- A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in AmericaCompletedPhase 4Novo Nordisk A/SNCT05579249Written as Naltrexone/Bupropion
- Addressing Dementia Via Agitation-Centered EvaluationCompletedPhase 2/3Axsome Therapeutics, Inc.NCT03226522Written as Bupropion
- AXS-05 Phase II Trial on Smoking BehaviorCompletedPhase 2James DavisNCT03471767Written as Bupropion SR
- Assessing Symptomatic Clinical Episodes in DepressionCompletedPhase 2Axsome Therapeutics, Inc.NCT03595579Written as Bupropion
- An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent PatientsStatus unknownPhase 2Axsome Therapeutics, Inc.NCT04971291Written as Bupropion SR
- A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive DisorderCompletedPhase 3Axsome Therapeutics, Inc.NCT02741791Written as Bupropion
- Leveraging EEG for Antidepressant Prediction With Duloxetine and BupropionWithdrawnPhase 4Alto NeuroscienceNCT04388189Written as Bupropion
- To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting ConditionsCompletedPhase 1SandozNCT00861939Written as WELLBUTRIN XL 300 mg Extended-Release Tablets GlaxoSmithKline
- Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder PatientsTerminatedPhase 4Ministry of Health & Welfare, KoreaNCT00926835Written as Paroxetine+Bupropion
- Varenicline and Smoking Cessation in SchizophreniaCompletedPhase 2University of MinnesotaNCT01111149Written as Bupropion HCl
- Algorithm Guided Treatment Strategies for Major Depressive DisorderStatus unknownPhase 4Shanghai Mental Health CenterNCT01764867Written as Bupropion
What changed recently
From the registry's own updates since Oct 18, 2026.
Results posted1
- SMART Trial to Predict Anhedonia Response to Antidepressant TreatmentOct 30, 2026NCT05537584
Stopped1
Codes
What other systems call Bupropion · ClinicalTrials.gg INT008536
- MeSH (NLM) D016642BupropionConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 01ZG3TPX31BUPROPIONConfirmed FDA, NLM, Wikidata
- RxNorm 42347Confirmed FDA, Wikidata
- Wikidata Q834280bupropionConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62012BupropionOne source FDA
- DrugBank DB01156One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D016642 | Bupropion | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 01ZG3TPX31 | BUPROPION | Confirmed FDA, NLM, Wikidata |
| RxNorm | 42347 | — | Confirmed FDA, Wikidata |
| Wikidata | Q834280 | bupropion | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62012 | Bupropion | One source FDA |
| DrugBank | DB01156 | — | One source Wikidata |
Also registered as bupropion hydrochloride (UNII ZG7E5POY8O · RxNorm 203204).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.